Your browser doesn't support javascript.
loading
Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma.
Yilma, Mignote; Mehta, Neil.
Afiliação
  • Yilma M; Department of Surgery, University of California San Francisco, 513 Parnassus Avenue, S-321, San Francisco, CA 94143, USA; National Clinician Scholars Program, University of California San Francisco, 513 Parnassus Avenue, S-321, San Francisco, CA 94143, USA. Electronic address: https://twitter.com/mignoteyilmaMD.
  • Mehta N; Department of Medicine, University of California San Francisco, Connie Frank Transplant Center, 400 Parnassus Avenue 7th Floor, San Francisco, CA 94143, USA. Electronic address: Neil.mehta@ucsf.edu.
Surg Oncol Clin N Am ; 33(1): 133-142, 2024 01.
Article em En | MEDLINE | ID: mdl-37945139
ABSTRACT
Liver transplantation continues to be the optimal treatment for hepatocellular carcinoma (HCC). Given the limited organ supply, patient selection for liver transplant must carefully balance tumor progression with risk of recurrence posttransplant. There are several pretransplant selection criteria that incorporate biomarkers as well as imaging modality to risk-stratify patients as we continue to look for the optimal transplant cutoff for patients with HCC, which should be transplant-center specific, and account for organ availability and dynamic response to locoregional therapy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Surg Oncol Clin N Am Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Surg Oncol Clin N Am Ano de publicação: 2024 Tipo de documento: Article